ArticleApplied biochemistry and biotechnology2026
ALKBH5 Accelerates the Progression of Head and Neck Squamous Cell Carcinoma by Decreasing Methylation of the lncRNA NEAT1.
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Defining the RNA Modification Landscape of Multiple Myeloma Reveals METTL3-Dependent mbioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Although N6-methyladenosine (m6A) demethylase alkylation repair homolog protein 5 (ALKBH5) is closely associated with the aggressiveness of head and neck squamous cell carcinoma (HNSCC), the underlying molecular mechanisms remain to be fully elucidated. In this study, we screened out a novel ALKBH5/lncRNA nuclear paraspeckle assembly transcript 1 (NEAT1)/miR-654-3p/HOXA10 axis that participated in the regulation of HNSCC development. Specifically, lncRNA NEAT1 was found to be highly expressed in HNSCC tissues and cells, and deletion of NEAT1 suppressed cell proliferation and tumorigenesis, and promoted apoptosis and autophagy to hamper cancer progression in HNSCC. Mechanistic experiments verified that the stability and expressions of NEAT1 were positively regulated by ALKBH5-mediated m6A demethylation, and ALKBH5 deletion induced a suppressive effect on HNSCC cell malignancies were all abrogated by overexpressing NEAT1. In addition, we evidenced that NEAT1 promoted Homeobox A10 (HOXA10) expression via sponging miR-654-3p in a competing endogenous RNA (ceRNA)-dependent manner, and both miR-654-3p inhibition and HOXA10 overexpression recovered cancer malignancies in the NEAT1-deficient HNSCC cells. Taken together, we concluded that ALKBH5-induced m6A demethylation increased the stability and expression levels of NEAT1, and elevated NEAT1 facilitated cancer progression in HNSCC through regulating the downstream miR-654-3p/HOXA10 axis. This study provided potential biomarkers for the diagnosis, treatment and prognosis of HNSCC in clinic.
Indexed as
Identifiers
41484734What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.